← Back to Analyst Consensus 
ARDT Buy
Ardent Health, Inc.
Current Price —
Implied Upside —
Analysts 19
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 23, 2026 | BMO Capital | initiate | — → Market Perform | — | 53% |
| Sep 18, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 50% |
| Aug 10, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Aug 6, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Aug 6, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jul 14, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jul 9, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 7, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Mar 10, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Mar 6, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 50% |
| Jan 20, 2026 | JP Morgan | maintain | Neutral → Neutral | $11 | 55% |
| Dec 18, 2025 | UBS | maintain | Buy → Buy | $14 | 54% |
| Dec 18, 2025 | Mizuho | maintain | Outperform → Outperform | $12 | 52% |
| Nov 24, 2025 | JP Morgan | maintain | Neutral → Neutral | $12 | 55% |
| Nov 18, 2025 | Mizuho | maintain | Outperform → Outperform | $13 | 52% |
| Nov 18, 2025 | Guggenheim | maintain | Buy → Buy | $15 | 52% |
| Nov 17, 2025 | Keybanc | downgrade | Overweight → Sector Weight | $0 | 52% |
| Nov 14, 2025 | RBC Capital | maintain | Outperform → Outperform | $16 | 55% |
| Nov 14, 2025 | Truist Securities | maintain | Buy → Buy | $13 | 54% |
| Nov 14, 2025 | Stephens & Co. | maintain | Overweight → Overweight | $17 | 54% |
| Nov 14, 2025 | Morgan Stanley | downgrade | Overweight → Equal-Weight | $12 | 54% |
| Nov 13, 2025 | B of A Securities | maintain | Underperform → Underperform | $10 | 53% |
| Oct 14, 2025 | Goldman Sachs | initiate | — → Neutral | $19 | 54% |
| Sep 10, 2025 | UBS | initiate | — → Buy | $17 | 54% |
| Aug 11, 2025 | JP Morgan | maintain | Neutral → Neutral | $15 | 55% |
| Aug 7, 2025 | Keybanc | maintain | Overweight → Overweight | $20 | 52% |
| Jul 16, 2025 | B of A Securities | downgrade | Neutral → Underperform | $14.6 | 53% |
| May 20, 2025 | Stephens & Co. | reiterate | Overweight → Overweight | $21 | 54% |
| May 15, 2025 | RBC Capital | reiterate | Outperform → Outperform | $21 | 55% |
| May 9, 2025 | Guggenheim | maintain | Buy → Buy | $18 | 52% |
| Apr 9, 2025 | Guggenheim | initiate | — → Buy | $16 | 52% |
| Apr 9, 2025 | Mizuho | maintain | Outperform → Outperform | $18 | 52% |
| Apr 1, 2025 | Stephens & Co. | reiterate | Overweight → Overweight | $22 | 54% |
| Mar 26, 2025 | Stephens & Co. | reiterate | Overweight → Overweight | $22 | 54% |
| Mar 4, 2025 | RBC Capital | maintain | Outperform → Outperform | $21 | 55% |
| Feb 27, 2025 | Stephens & Co. | reiterate | Overweight → Overweight | $22 | 54% |
| Jan 21, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $22 | 54% |
| Jan 6, 2025 | Truist Securities | maintain | Buy → Buy | $21 | 54% |
| Nov 14, 2024 | RBC Capital | reiterate | Outperform → Outperform | $23 | 55% |
| Nov 12, 2024 | Leerink Partners | maintain | Outperform → Outperform | $25 | 50% |
| Nov 6, 2024 | B of A Securities | downgrade | Buy → Neutral | $19 | 53% |
| Oct 11, 2024 | Keybanc | initiate | — → Overweight | $24 | 52% |
| Sep 19, 2024 | Stephens & Co. | reiterate | Overweight → Overweight | $24 | 54% |
| Aug 16, 2024 | Truist Securities | reiterate | Buy → Buy | $22 | 54% |
| Aug 16, 2024 | Loop Capital | maintain | Buy → Buy | $21 | 54% |
| Aug 15, 2024 | Stephens & Co. | reiterate | Overweight → Overweight | $24 | 54% |
| Aug 12, 2024 | B of A Securities | initiate | — → Buy | $22 | 53% |
| Aug 12, 2024 | RBC Capital | initiate | — → Outperform | $23 | 55% |
| Aug 12, 2024 | Citigroup | initiate | — → Buy | $21 | 54% |
| Aug 12, 2024 | Loop Capital | initiate | — → Buy | $18 | 54% |
Price Target Trend
Apr 2, 2026 Latest: $12.67 Oct 24, 2026
EPS Estimates
0q $0.24
Lo: $0.13 Hi: $0.34
4 analysts ▲1
+1y $1.25
Lo: $1.09 Hi: $1.49
4 analysts +1q $0.34
Lo: $0.28 Hi: $0.43
4 analysts 0y $1.09
Lo: $0.81 Hi: $1.56
4 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days